Co-founded by Dr. George Wang and Dr. John L. Xu in early 2017 and located in the International Medical Park, Pudong, Shanghai, Mab-Legend Biotech Co., Ltd. is built upon the mature CDMO technology platform of Mab-Venture Biopharma and focuses on the discovery, development and commercialization of innovator biologic medicines, including monoclonal and bispecific antibodies and antibody-drug conjugates, for the treatment of cancers, inflammatory and autoimmune disorders as well as cardiovascular and metabolic diseases.
Based on a deep understanding of the disease biology, we choose genetically, epidemiologically, or pharmacologically validated and tractable molecular targets for antibody discovery and strive to develop either first-in-class or best-in-class therapies for the world-wide markets, with the goal of easing suffering, saving lives and improving life quality.
Company Details
- Employees
- 2
- Address
- 178 Banxia Road, Suite 1-302,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mab-legend.com
- HQ
- Pudong, Shanghai
Mab-Legend Biotech Questions
Mab-Legend Biotech's website is http://www.mab-legend.com
Mab-Legend Biotech's LinkedIn profile is https://cn.linkedin.com/company/mab-legend
Mab-Legend Biotech has
2 employees.
View email and phone details for 2
employees at Mab-Legend Biotech.
Mab-Legend Biotech's industry is
Biotechnology Research
Mab-Legend Biotech's top competitors are
Genscript,
Iba,
Regeneron,
Legend Biotech,
Johnson & Johnson,
Bristol Myers Squibb,
Pfizer,
Amgen,
Genmab,
Cytovant Sciences Co., Ltd..
Mab-Legend Biotech's categories are Biotechnology Research
